Sanofi's net rises 54% on growth of core businesses

Article Abstract:

Sanofi-Synthelabo SA posted an increase of 54% in its net profits for the 2000 year. The company posted 961 million euros in net earnings for the year.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Merck's net rises despite lag in sales of arthritis drug

Article Abstract:

Merck and Co. posted an increase of 11% in its 2001 first-quarter net income. The company, which posted disappointing sales of its Vioxx arthritis drug, posted $1.66 billion (1.84 billion euros) in quarterly net income.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Aventis posts 31% increase in net, raises its targets for full year

Article Abstract:

Aventis S.A. posted an increase of 31% in its net profits for the 2001 second-quarter. The company posted 391 million euros in net profits for its core pharmaceutical business.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: